A well-documented role of BDNF/TrkB signaling in memory formation and retention via cytoskeletal reorganization[16], [17] has been driving the interest in studying the expression of these molecules in relation to AD pathological hallmarks[24]. Here, NTRK2 is linked to Alzheimer disease.